[HTML][HTML] Long non-coding RNAs regulated NF-κB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs

S Ahmad, M Abbas, MF Ullah, MH Aziz… - Seminars in cancer …, 2022 - Elsevier
Cancer metastasis is a major reason for the cancer-associated deaths and a role of long non-
coding RNAs (lncRNAs) in cancer metastasis is increasingly being realized. Among the …

Epigenetic regulation in breast cancer: Insights on epidrugs

A Kim, K Mo, H Kwon, S Choe, M Park, W Kwak… - Epigenomes, 2023 - mdpi.com
Breast cancer remains a common cause of cancer-related death in women. Therefore,
further studies are necessary for the comprehension of breast cancer and the revolution of …

Let-7a/cMyc/CCAT1/miR-17–5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1

NA Selem, H Nafae, T Manie, RA Youness… - Pathology-Research and …, 2023 - Elsevier
Background Triple negative breast cancer (TNBC) is an immunogenically hot tumor. The
immune checkpoint blockades (ICBs) have been recently emerged as promising therapeutic …

Efficacy of cell-free DNA as a diagnostic biomarker in breast cancer patients

I Khurram, MU Khan, S Ibrahim, A Saleem, Z Khan… - Scientific Reports, 2023 - nature.com
Breast cancer is the most prevalent and leading cause of mortality worldwide among
women. Cell-free DNA (cfDNA) analysis is an alternative quantitative approach to …

Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update

P Mondal, J Natesh, D Penta, SM Meeran - Seminars in Cancer Biology, 2022 - Elsevier
Epigenetic modifications are heritable yet reversible, essential for normal physiological
functions and biological development. Aberrant epigenetic modifications, including DNA …

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer

P Mondal, SM Meeran - Frontiers in Pharmacology, 2023 - frontiersin.org
Platinum-based drugs are the first line of therapeutics against many cancers, including lung
cancer. Lung cancer is one of the leading causes of cancer-related death worldwide …

The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance

P Mondal, SM Meeran - Cancer and Metastasis Reviews, 2024 - Springer
Resistance to therapeutic agents is one of the major challenges in cancer therapy.
Generally, the focus is given to the genetic driver, especially the genetic mutation behind the …

CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 …

F Moradi, F Mohajerani, M Sadeghizadeh - Life Sciences, 2022 - Elsevier
Aims Tamoxifen (TAM) selectively modulates estrogen receptors and is widely used in
breast cancer treatment. However, resistance to this drug appears in 40% of estrogen …

Quercetin modulates signal transductions and targets non-coding RNAs against cancer development

M Homayoonfal, H Gilasi, Z Asemi, MK Mahabady… - Cellular …, 2023 - Elsevier
In recent decades, various investigations have indicated that natural compounds have great
potential in the prevention and treatment of different chronic disorders including different …

[HTML][HTML] Non-coding RNA as a biomarker in lung cancer

C Suri, S Swarnkar, L Bhaskar, HK Verma - Non-coding RNA, 2024 - mdpi.com
Introduction: Lung cancer remains one of the most prevalent and deadly cancers globally,
with high mortality rates largely due to late-stage diagnosis, aggressive progression, and …